Based on current trends in cardiovascular health for women, cardiovascular risk and disease are projected to increase through 2050.

Fenebrutinib significantly reduced the annualized relapse rate in patients with relapsing multiple sclerosis compared with teriflunomide.

New genetic data shows no meaningful overlap between vitamin B12 status determinants and Parkinson disease outcomes in clinical cohorts.

The FDA expands Palynziq approval to include pediatric patients aged 12 years and older with phenylketonuria and uncontrolled blood Phe levels.

A new drug may help treat and eventually eliminate sleeping sickness by improving adherence and accessibility to treatment.

Rising vitamin K refusal rates correlated with later healthcare hesitancy, including higher likelihoods of refusing childhood immunizations.